| __timestamp | Amicus Therapeutics, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 4534000000 |
| Thursday, January 1, 2015 | 76943000 | 5920000000 |
| Friday, January 1, 2016 | 104793000 | 4940000000 |
| Sunday, January 1, 2017 | 149310000 | 6411000000 |
| Monday, January 1, 2018 | 270902000 | 6345000000 |
| Tuesday, January 1, 2019 | 286378000 | 6148000000 |
| Wednesday, January 1, 2020 | 308443000 | 11143000000 |
| Friday, January 1, 2021 | 272049000 | 10195000000 |
| Saturday, January 1, 2022 | 276677000 | 9509000000 |
| Sunday, January 1, 2023 | 152381000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
Unveiling the hidden dimensions of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company and Amicus Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Bristol-Myers Squibb consistently allocated substantial resources, with R&D expenses peaking at approximately $11 billion in 2020, reflecting a 145% increase from 2014. In contrast, Amicus Therapeutics, a smaller player, showed a more modest growth trajectory, with R&D spending increasing by over 500% during the same period, reaching its highest in 2020. This disparity highlights the scale and strategy differences between a pharmaceutical giant and a nimble biotech firm. As the industry continues to innovate, these spending patterns offer insights into how companies prioritize and drive their research agendas.
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
R&D Insights: How Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Amicus Therapeutics, Inc. vs Mesoblast Limited